Tamsulosin HCL 0.4 MG capsule 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26FA0PA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,508
Award facts
- Contract value 100% obligated
- $5,508.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for Tamsulosin HCL 0.4 mg capsules (1,000 count) valued at $5,508.19. The contract employs firm fixed pricing with an ultimate completion date of December 12, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. The company's extensive portfolio includes both brand-name and generic medications across multiple therapeutic domains, delivered through competitively awarded contracts that demonstrate its capability to meet rigorous federal procurement standards. This delivery order for Tamsulosin HCL, a common medication used to treat benign prostatic hyperplasia, exemplifies the routine pharmaceutical commodity deliveries that support Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA0PA?
SPE2DR26FA0PA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FA0PA worth?
The government has obligated $5,508 on SPE2DR26FA0PA.
Is contract SPE2DR26FA0PA an order under another contract?
Yes. SPE2DR26FA0PA is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0PA competed?
The extent of competition for SPE2DR26FA0PA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award